NYNing Yang

Ning Yang

*This is an algorithmically generated author record based on publicly available information.

Ning Yang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Zhang

    Key Technology Engineering Laboratory of Immunoassay and Liquid Chromatography In Vitro Diagnosis in Shenzhen, Lifotronic Technology Co., Ltd., Shenzheng 518005, China

    1 shared publication
  • Dandan Shi

    Key Technology Engineering Laboratory of Immunoassay and Liquid Chromatography In Vitro Diagnosis in Shenzhen, Lifotronic Technology Co., Ltd., Shenzheng 518005, China

    1 shared publication
  • Dezhong Xie

    Key Technology Engineering Laboratory of Immunoassay and Liquid Chromatography In Vitro Diagnosis in Shenzhen, Lifotronic Technology Co., Ltd., Shenzheng 518005, China

    1 shared publication
  • Feng Liu

    Key Technology Engineering Laboratory of Immunoassay and Liquid Chromatography In Vitro Diagnosis in Shenzhen, Lifotronic Technology Co., Ltd., Shenzheng 518005, China

    1 shared publication
  • Guixue Wang

    Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing 400044, China

    1 shared publication
  • Junli Huang

    Chongqing University

    1 shared publication

Latest Publications

  • Open Access

    A Novel High-Throughput and Sensitive Electrochemiluminescence Immunoassay System

    by Xiancheng Liu, Shuang Zhao, Yan Xu, Bo Zhang, Junli Huang, Feng Liu, Ning Yang, Wenhua Lu, Dandan Shi, Dezhong Xie, et al.

    (1) Background: In vitro diagnostic (IVD) tests are the main means of obtaining diagnostic information for clinical purposes. The electrochemiluminescence immunoassay (ECLIA) has become an important in vitro diagnostic technique. It has unique advantages and broad market prospects due to its sensitivity, detection limit, detection range and reagent stability. At present, there is a need to develop and optimize electrochemiluminescence immunoassay subsystems to achieve high-throughput outputs and accurate detection of instruments to promote their clinical application. (2) Methods: On the basis of the demand for clinical testing instruments with high detection accuracy and speed, this study constructed an electrochemiluminescence immunoassay system by designing magnetic separation modules, introducing PMT and optimizing the system timing regulation capability. (3) Results: The magnetic separation modules can increase the detection accuracy, the PMT system increases the detection sensitivity and optimized system timing can achieve maximum test output. Furthermore, this system performs well in terms of its linearity, detection limit, signal-to-noise ratio, precision and accuracy. (4) Conclusions: The electrochemiluminescence immunoassay system is capable of high throughput with good sensitivity and accuracy, meeting the basic requirements of clinical applications for detection capacity and output throughput.